Acute Myocardial Infarction Associated with Initial Alemtuzumab Infusion Cycle in Relapsing-Remitting Multiple Sclerosis

We report a 30-year-old woman with relapsing-remitting multiple sclerosis who developed a type 2 non-ST elevated myocardial infarction (NSTEMI) during her first alemtuzumab infusion cycle. While acute coronary syndrome has been described with alemtuzumab in the treatment of lymphoma, alemtuzumab-associated cardiac ischemia in multiple sclerosis is uncommon and can occur in patients without cardiovascular risk factors.
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research